about
Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord InjuryThe role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuriesCardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative StressOxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegenerationTherapeutic approaches for spinal cord injuryDrug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injuryThe effect of mild traumatic brain injury on peripheral nervous system pathology in wild-type mice and the G93A mutant mouse model of motor neuron diseaseIn vivo two-photon imaging of axonal dieback, blood flow, and calcium influx with methylprednisolone therapy after spinal cord injury.Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injuryFormyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signalingAntioxidant therapies in traumatic brain and spinal cord injuryNeuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats.Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisolone.Hydrogen peroxide administered into the rat spinal cord at the level elevated by contusion spinal cord injury oxidizes proteins, DNA and membrane phospholipids, and induces cell death: attenuation by a metalloporphyrinNeuroprotective effects of sildenafil in experimental spinal cord injury in rabbits.New Prophylactic and Therapeutic Strategies for Spinal Cord InjuryMetformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes.Method for the assessment of effects of a range of wavelengths and intensities of red/near-infrared light therapy on oxidative stress in vitroLewis, Fischer 344, and sprague-dawley rats display differences in lipid peroxidation, motor recovery, and rubrospinal tract preservation after spinal cord injury.Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury.Effect of BDNF and Other Potential Survival Factors in Models of In Vitro Oxidative Stress on Adult Spinal Cord-Derived Neural Stem/Progenitor CellsLipid peroxidation in brain or spinal cord mitochondria after injuryDietary Supplementation with Organoselenium Accelerates Recovery of Bladder Expression, but Does Not Improve Locomotor Function, following Spinal Cord Injury.Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury.Neuroprotective effects of the Buyang Huanwu decoction on functional recovery in rats following spinal cord injury.Correlation of Oxidative and Antioxidative Processes in the Blood of Patients with Cervical Spinal Cord Injury.MP Resulting in Autophagic Cell Death of Microglia through Zinc Changes against Spinal Cord InjuryConditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantationRhoA Signaling and Synaptic Damage Occur Within Hours in a Live Pig Model of CNS Injury, Retinal Detachment.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Concise review: Spinal cord injuries: how could adult mesenchymal and neural crest stem cells take up the challenge?Say "no" to spinal cord injury: is nitric oxide an option for therapeutic strategies?Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease.From demyelination to remyelination: the road toward therapies for spinal cord injury.GRP78 suppresses lipid peroxidation and promotes cellular antioxidant levels in glial cells following hydrogen peroxide exposure.Down-regulation of apurinic/apyrimidinic endonuclease 1 (APE1) in spinal motor neurones under oxidative stress.Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury.Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone.
P2860
Q26740237-FF3EBC27-0C03-4EAB-BBF2-C7E06E629A94Q26746135-2836B039-5E24-4D3F-B89A-05DE11BAFEECQ26773004-69D6E3E1-F365-447A-9BB8-FD36217CC437Q26995219-81864EDB-B60D-44F7-B5BD-7774ED04A7C0Q26999949-37529398-C4C4-4408-85A9-79894CA0D5A7Q28085174-D9C2ACF3-4A1B-4A5C-97B8-EC9F65BE0354Q28396641-EF8218E8-B93B-417E-B188-9315ACA1370DQ30410575-2046EAE3-E5A4-49A3-960C-524584838A56Q33651175-B900B682-559B-424A-858F-875A5729C8ECQ33670941-75E1DA2F-42F4-4306-BA54-40787E8AD877Q34049949-266B86A8-F589-4940-8B70-1AD4A08C93FCQ34345646-80084B8A-9C9A-4270-8EB6-B9DE0363E6F0Q34604444-6DD36073-5EA2-4BC5-96B8-D14B2F68980EQ35007166-7091DD3D-DC23-458C-8024-E20920E0E52DQ35194377-59D9BB9D-6795-4FE1-A34B-49A157645AF3Q35332802-FEFB0489-2F4E-4773-B562-6D85C64A917EQ35532277-3DDE30AA-8E26-4E66-9FC3-54D2DA35B83CQ35600290-6C690CB2-8E14-4C33-B9C6-BF7FC893DB37Q35609141-FCABD183-82A8-457D-BC7A-817A20736751Q35729623-200A35AA-D07B-4BC8-9D1A-3FD81FD53E65Q35835906-DA3E0BEA-12E8-420A-B44B-D4059F28BFFEQ35864073-A75813A7-EDDF-4000-AAEA-39B8ADF67ACEQ35908148-F3521F9F-FB87-4E1D-9904-502EA28D4A1FQ36321592-FE13F6B2-4075-496F-8FD4-95F455A90786Q36499186-EB3FA8B0-DB93-43AA-B944-7AA27310B8D2Q36530407-64C8244C-D9BF-4BF1-BA05-CCA790BCBACBQ36530866-F2D1B4C0-BE03-45FB-BF5E-5AE52FCF47E2Q37125914-C35B4987-6099-4A96-8335-C521406796A2Q37152871-281B4C15-432B-42C7-B305-3224FD5837D1Q38022179-14BD46F5-BB08-4604-B13E-C14CA76FA187Q38155135-BD2C026B-7CA4-4779-90DB-33C09F283B21Q38201773-BCC5EE65-20C2-4EEE-B061-ADD2D14BAAFAQ38237635-A44D45D9-B855-498D-B4F7-3AAEA7580C9AQ38264684-F7C50B07-AC8A-4154-ACE0-ABD88EC01A7BQ38366783-13AFD3F1-CFDA-4DD2-9313-F4154622C158Q39029371-68CF9E63-AA11-4A26-B35E-B0148C64FCB7Q39133838-822765A0-55D1-4B3B-A22A-8BC6731B0DB7Q39374470-7640B780-8AA8-4E61-BB7F-779FB6B30F9DQ39428068-D85EBD8C-8777-4C4A-8D77-79722B2BEF46Q40055114-0051C572-0E36-4DAA-9171-E5195939C4F0
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antioxidant therapies for acute spinal cord injury.
@ast
Antioxidant therapies for acute spinal cord injury.
@en
Antioxidant therapies for acute spinal cord injury.
@nl
type
label
Antioxidant therapies for acute spinal cord injury.
@ast
Antioxidant therapies for acute spinal cord injury.
@en
Antioxidant therapies for acute spinal cord injury.
@nl
prefLabel
Antioxidant therapies for acute spinal cord injury.
@ast
Antioxidant therapies for acute spinal cord injury.
@en
Antioxidant therapies for acute spinal cord injury.
@nl
P2860
P1433
P1476
Antioxidant therapies for acute spinal cord injury.
@en
P2093
Edward D Hall
P2860
P2888
P304
P356
10.1007/S13311-011-0026-4
P577
2011-04-01T00:00:00Z